scorecardresearch
Add as a preferred source on Google
Friday, May 1, 2026
TopicZydus Cadila

Topic: Zydus Cadila

2 months after vaccine approval, Covid shots for kids stuck on list of comorbidities, procedure

Abantika Ghosh -
Zycov-D is the lone vaccine cleared for use in children in India. However, expert panel still thrashing out some issues to streamline the rollout for parents.

Modi govt drives hard bargain, ZyCov-D vaccine could cost Rs 275/dose or even less

Abantika Ghosh -
The world’s first DNA vaccine for Covid manufactured by Gujarat-based Zydus Cadila is delivered using a special applicator costing Rs 30,000.

Vaccine makers upset over ‘differential pricing’ for ZyCov-D, and lack of clarity on exports

Abantika Ghosh -
ZyCov-D has reportedly been priced by the company at Rs 1,900 for three doses while the others cost between Rs 205-215 per dose.

6 shots per patient, Rs 30,000 applicator gun complicate govt talks for ZyCov-D vaccine

Abantika Ghosh -
World's first DNA vaccine, ZyCov-D is a 3-dose vaccine (administered in 2 injections each time) which requires a special needle-free applicator.

ZyCov-D price talks still on, but India begins training for use of needle-free applicator

Abantika Ghosh -
First instalment of ZyCov-D, a three-dose Covid vaccine manufactured by Zydus Cadila, is expected next month. Vaccine doesn't require a needle injection to be administered.

Zycov D is 66% effective against Delta variant of SARS-Cov-2, claims Zydus Cadila

Abantika Ghosh -
Zydus' claim comes a day after it being given emergency use authorisation in India, and is the only vaccine approved for use in 12-18 years age group.

Three-dose ZyCoV-D vaccine could be just two doses, says pharma firm Zydus Cadila

Himani Chandna -
Zydus Cadilla says its test data shows that the vaccine appears to be just as effective in 2 doses as 3, and will be administered 28 days apart.

Zydus Cadila applies for approval to ZyCov-D, India’s 1st Covid vaccine tested on 12-18-yr-olds

Himani Chandna -
If ZyCov-D gets the approval, it will be the fifth vaccine authorised for use in India after Covishield, Covaxin, Sputnik V and Moderna.

India’s ZyCoV-D set to become world’s first DNA Covid vaccine as govt approval likely soon

Abantika Ghosh -
Gujarat-based Zydus Cadila has told Modi govt that it could apply for emergency use authorisation for ZyCoV-D vaccine in the next 10-12 days.

Zydus’s antiviral drug Virafin gets emergency approval to treat moderate Covid patients

Kairvy Grewal -
In statement, Zydus Cadila says phase 3 clinical trial data showed Virafin reduced oxygen requirement in patients, & and that a significant number of them tested negative by 7th day.
Load more

On Camera

YourTurn

Opinion

India’s real estate will meet the reality of agentic AI

Andy Mukherjee -
New Delhi: The outsourcing industry, India’s largest white-collar employer, is a juggernaut that has all but stopped moving. The dollar revenue at the top...

Keeping CAPF in Bengal for 60 days raises constitutional questions. It’s not an occupying force

History of Indians in the Arab world—port builders, Jat governor, translators, and slaves

+TFP

Economy

Adani’s giant copper plant hits technical setbacks in first year

Julian Luk -
The 500,000 tonne-per-year plant produced just 94,000 tonnes of refined copper from April 2025 to February this year.

Defence

Indian drone tech company ideaForge signs MoU with Japanese firm to develop next-gen AI powered drones

Debdutta Chakraborty -
By pairing Indian drone engineering with Japanese semiconductor expertise, the two firms aim to develop more advanced autonomous systems tailored to both defence & commercial use.

National Interest

Trump, Netanyahu’s Iran gamble: The regime change rebound

Shekhar Gupta -
American objectives are unmet. They neither have muscle nor motivation to resume the war. As for Iran, the regime didn’t just survive, it’s now led by more radical individuals.

Follow us

Copyright © 2026 Printline Media Pvt. Ltd. All rights reserved.